Mandatum Life Insurance Company’s Bristol-Myers Squibb BMY Stock Holding History

Mandatum Life Insurance Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-37,939	Closed	-$2.25M	–	85
2021 Q3	$2.25M	Hold	37,939	–	–	0.42%	61
2021 Q2	$2.54M	Hold	37,939	–	–	0.46%	61
2021 Q1	$2.4M	Hold	37,939	–	–	0.47%	60
2020 Q4	$2.35M	Hold	37,939	–	–	0.49%	59
2020 Q3	$2.29M	Sell	37,939 -491	-1%	-$29.6K	0.5%	52
2020 Q2	$2.26M	Buy	38,430 +491	+1%	+$29.4K	0.54%	48
2020 Q1	$2.12M	Hold	37,939	–	–	0.57%	50
2019 Q4	$2.44M	Buy	+37,939	New	+$2.17M	0.51%	55
2019 Q3	–	Sell	-21,425	Closed	-$972K	–	136
2019 Q2	$972K	Buy	21,425 +3,677	+21%	+$171K	0.2%	94
2019 Q1	$847K	Buy	+17,748	New	+$884K	0.18%	99

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mandatum Life Insurance Company's BMY Position: Q4 2021 in Review

Mandatum Life Insurance Company sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 37,939 shares — an estimated $2.25M sold.

Mandatum Life Insurance Company first reported a position in BMY in Q1 2019 and held it in 10 quarters. The position peaked at $2.54M in Q2 2021. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Mandatum Life Insurance Company reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Mandatum Life Insurance Company sold 37,939 Bristol-Myers Squibb shares in Q4 2021, an estimated $2.25M.
Mandatum Life Insurance Company first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 10 quarters.
Mandatum Life Insurance Company's Bristol-Myers Squibb position peaked at $2.54M in Q2 2021.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Mandatum Life Insurance Company's 13F filing for Q4 2021, filed 9 Feb 2022.